LONDON, and BILTHOVEN, The Netherlands, Nov. 29 /PRNewswire-FirstCall/ -- Today Medicsight PLC (http://www.medicsight.com), a subsidiary company of Medicsight, Inc. , a leading developer of computer-aided detection (CAD) technologies and software, and 3mensio Medical Imaging BV (http://www.3mensio.com), a leading provider of advanced 3D medical visualization products announced the signing of a partnership agreement to incorporate Medicsight’s ColonCAD and LungCAD image analysis software tools within 3mensio’s medical imaging product offerings.
The agreement will allow the incorporation and distribution of Medicsight’s ColonCAD and LungCAD image analysis software within advanced clinical applications based on the 3viseon(TM) 3D imaging workstation.
“We are extremely pleased to partner with 3mensio for the incorporation of our CAD image analysis software into the 3viseon family of products,” said Etienne Vanderstokker, CEO of Medicsight PLC. “This joint collaboration further enhances our strategy to deliver excellent clinical applications using our partner channels, and will ensure that our users will be able to benefit from advances in Graphics Processing Unit technology.”
“By collaborating with leading CAD application provider Medicsight PLC, we can rapidly deliver clinically relevant applications into the marketplace,” says Frank Wessels, CEO and founder of 3mensio Medical Imaging BV. “We are particularly proud of this since it fits within our strategy to provide leading-edge 3D solutions collaborating with companies with an excellent clinical track record like Medicsight.”
The 3viseon CAD applications with Medicsight colon and lung advanced algorithms are designed to assist users in detection of colon and lung lesions and will potentially reduce the ever increasing workload of radiologists.
Both companies are presenting at the 92nd annual meeting of the Radiology Society of North America, which is being held in Chicago through December 1, 2006. The companies are demonstrating the first results of the partnership at their booths, Medicsight PLC booth (#5544) and the 3mensio booth (#5104), both in South Building A.
About Medicsight PLC
Medicsight is a pioneer in the development of enterprise-wide computer- aided detection (CAD) and Computer Assisted Reader (CAR) software used by the imaging community to aid in earlier detection of disease. Medicsight’s unique software solutions have been validated using some of the world’s largest and most population-diverse verified CT scan databases to help clinicians identify, measure, and analyze suspicious pathology of the lung and colon. The company’s products include ColonCAD and ColonCAR, the first technology available for CT colonography, and LungCAD and LungCAR. Medicsight continues to develop CAD software for a variety of conditions that can help in the early detection of disease and ultimately improve patient outcomes. Headquartered in London, Medicsight, Inc. employs more than 60 people and also has offices in the United States, Japan, and China. Product and company information can be found on http://www.medicsight.com.
About 3mensio Medical Imaging BV
3mensio Medical Imaging (http://www.3mensio.com) provides complete advanced 3D medical imaging workstations and integrated solutions. The ever increasing workload makes 3D a primary tool for radiologists to enhance their productivity. 3mensio’s technology has its roots in the computer gaming industry and provides real-time advanced 3D visualization functionality within the healthcare market, independent of the imaging acquisition device. Standard PC technology in the 3viseon(TM) 3D Imaging Workstation ensures that 3viseon(TM) 3D Imaging Workstations remain affordable. Visit http://www.3viseon.com for more information about these new products.
All forward-looking statements are made pursuant to the ‘safe harbor’ provisions of the Private Securities Litigation Reform Act of 1995. Forward- looking statements are based on current management expectations that involve risks and uncertainties that may result in such expectations not being realized. Potential risks and uncertainties include, but are not limited to, the risks described in company filings with the Securities and Exchange Commission.
Contacts: For more information: Medicsight PLC Medicsight, Inc. Dr. Ravi Bickram K Shrestha Alex van Klaveren VP Commercial & Operations 1410 Broadway 66 Hammersmith Road 22nd Floor London W14 8UD New York, NY 10018 United Kingdom +1 646-468-8086 Phone: +44 (0)20 7605 7977 alex.van.klaveren@medicsight.com Fax: +44 (0)20 7605 7951 Email: ravi.shrestha@medicsight.com Investors Stephanie Carrington / Zack Kubow 3mensio Medical Imaging BV +1 646-536-7017 / 7020 Pieter Goedhart scarrington@theruthgroup.com VP Sales & Marketing zkubow@theruthgroup.com 3mensio Medical Imaging BV Jan Steenlaan 3, Media 3723 BS, Bilthoven Dave Baldridge The Netherlands +1 314-982-7782 Phone: +31 30 274 0000 david.baldridge@fleishman.com Fax: +31 30 850 0320 E-mail: pieter.goedhart@3mensio.com
Medicsight, Inc.
CONTACT: Dr. Ravi Bickram K Shrestha, VP Commercial & Operations,Medicsight PLC, +44-20-7605-7977, fax - +44-20-7605-7951,ravi.shrestha@medicsight.com; Alex van Klaveren, Medicsight, Inc.,+1-646-468-8086, alex.van.klaveren@medicsight.co; Pieter Goedhart, VP Sales& Marketing, 3mensio Medical Imaging BV, +31-30-274-0000, fax -+31-30-850-0320, pieter.goedhart@3mensio.com; Investors - StephanieCarrington, +1-646-536-7017, scarrington@theruthgroup.com, or Zack Kubow,+1-646-536-7020, zkubow@theruthgroup.com, both of the Ruth Group; Media -Dave Baldridge, +1-314-982-7782, david.baldridge@fleishman.com
